Axel REE Advances Caladão Project with Focus on De-Risking ISR Pathway for Rare Earths and Gallium
Axel REE (ASX: AXL) has announced significant advancements at its Caladão project in Brazil, focusing on the implementation of in-situ recovery (ISR) pilot tests slated for 2026. This initiative aims to de-risk the extraction of rare earth elements (REE) and gallium, aligning with the growing global demand for critical minerals and the strategic shift towards non-China supply chains. The project boasts a robust JORC (2012) Inferred Mineral Resource of 572 million tonnes (Mt) of rare earth oxides, including a notable gallium resource of 439 Mt. This resource base is underpinned by a strong magnet rare earth (MREO) profile, which is particularly relevant given the increasing emphasis on securing supply chains for these critical materials.
The strategic context for Axel REE is compelling, as the company operates within a market increasingly focused on supply-chain security, particularly for magnet REEs and gallium. As Western markets and technology manufacturers seek to diversify their critical mineral sources away from Chinese dominance, the Caladão project presents a significant opportunity. The ISR method proposed by Axel REE is designed to minimize capital expenditure and environmental impact, utilizing a modular processing approach that could facilitate a cost-effective pathway to production. This method involves circulating a mild lixiviant through the orebody, which is expected to yield a lower surface disturbance compared to traditional mining techniques.
From a financial perspective, Axel REE reported a cash balance of A$8.71 million as of June 2025, which provides a runway for the upcoming testing programs. The company is currently equity-funded, navigating the capital-intensive phases of metallurgical testing and pilot trials. Given its current cash position and the anticipated burn rate, the company appears adequately funded to execute its immediate work programs, although reliance on equity financing poses a potential dilution risk in the future. The market capitalisation of Axel REE stands at approximately A$10 million, indicating a relatively small scale within the sector, which may limit its ability to attract larger institutional investors without demonstrating tangible progress in its development pathway.
In terms of valuation, comparing Axel REE with direct peers reveals a nuanced picture. For instance, fellow ASX-listed companies such as Cobalt Blue Holdings (ASX: COB) and Hastings Technology Metals (ASX: HAS) operate within the critical minerals space, albeit with different commodity focuses. Cobalt Blue Holdings has a market capitalisation of approximately A$60 million and an enterprise value of A$50 million, while Hastings Technology Metals, focused on rare earths, has a market cap of A$200 million and an enterprise value of A$180 million. Axel REE's valuation metrics, particularly its market capitalisation relative to its resource base, suggest that it is currently undervalued compared to its peers, especially considering the strategic importance of its non-China supply narrative.
The execution track record of Axel REE will be critical as it moves forward. The company has set clear milestones with the upcoming column and pilot field trials throughout 2026, which are essential for demonstrating the viability of the ISR concept. Investors will be closely monitoring these trials, as successful outcomes will not only validate the extraction method but also serve as a catalyst for a potential re-rating of the company. However, there are inherent risks associated with this approach, particularly concerning the hydrogeological and metallurgical parameters that need to be proven. Any delays or failures in these trials could significantly impact the project timeline and investor sentiment.
The next measurable catalyst for Axel REE is the commencement of the ISR pilot tests, expected to take place throughout 2026. These tests are pivotal for the company, as they will provide critical data on the extraction efficiency and environmental impact of the proposed ISR method. The successful execution of these trials will be a key determinant of the project's future viability and could lead to a re-evaluation of the company's market position.
In conclusion, Axel REE's announcement regarding the advancement of the Caladão project is classified as significant. The focus on de-risking the ISR pathway for rare earths and gallium aligns with broader market trends towards securing non-China supply chains. While the company's current financial position appears sufficient to support its immediate testing programs, the reliance on equity funding raises potential dilution concerns. The upcoming pilot tests will be crucial in determining the project's feasibility and could serve as a catalyst for a positive re-rating of the company's valuation. Overall, Axel REE is well-positioned within the critical minerals landscape, but it must navigate the inherent risks associated with its development strategy to unlock its full potential.